You are here

2016 Publications

Joachim A, Munseri PJ, Nilsson C, Bakari M, Aboud S, Lyamuya EF, Tecleab T, Liakina V, Scarlatti G, Robb M, Earl P, Moss B, Wahren B, Mhalu F, Ferarri G, Sandström E, Biberfeld G. 2016. Three-year durability of immune responses induced by HIV-DNA and HIV-modified vaccinia virus Ankara and effect of a late HIV-MVA boost in Tanzanian volunteers. AIDS Res Hum Retroviruses. 2016 Dec 27. [Epub ahead of print]. PMID: 28027665.

Karnasuta C, Akapirat S, Madnote S, Savadsuk H, Puangkaew J, Rittiroongrad S, Rerks-Ngarm S, Nitayaphan S, Pitisuttithum P, Kaewkungwal J, Tartaglia J, Sinangil F, Francis DP, Robb M, de Souza M, Michael NL, Excler JL, Kim JH, O'Connell RJ, Karasavvas N. 2016. Comparison of Antibody Responses Induced by RV144, VAX003 and VAX004 Vaccination Regimens. AIDS Res Hum Retroviruses. 2016 Dec 22. [Epub ahead of print]. PMID: 28006952.

Luo K, Liao HX, Zhang R, Easterhoff D, Wiehe K, Gurley TC, Armand LC, Allen AA, Von Holle TA, Marshall DJ, Whitesides JF, Pritchett J, Foulger A, Hernandez G, Parks R, Lloyd KE, Stolarchuk C, Sawant S, Peel J, Yates NL, Dunford E, Arora S, Wang A, Bowman CM, Sutherland LL, Scearce RM, Xia SM, Bonsignori M, Pollara J, Edwards RW, Santra S, Letvin NL, Tartaglia J, Francis D, Sinangil F, Lee C, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Michael NL, Kim JH, Alam SM, Vandergrift NA, Ferrari G, Montefiori DC, Tomaras GD, Haynes BF, Moody MA. 2016. Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques. JCI Insight. 2016 Dec 8; 1(20):e88522. PMID: 27942585.

Njoku OS, Manak MM, O'Connell RJ, Shutt AL, Malia JA, Heipertz RA Jr, Tovanabutra S, Milazzo MJ, Akintunde GA, Alabi AS, Suleiman A, Ogundeji AA, Kene TS, Nelson R, Ayemoba OR, Singer DE, Robb ML, Peel SA, Michael NL. 2016. An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria. PLoS One. 2016 Dec 9; 11(12):e0166711.PMID: 27936236. 

McFarland EJ, Powell TM, Onyango-Makumbi C, Zhang W, Melander K, Naluyima P, Okurut S, Eller MA, Fowler MG, Janoff EN. 2016. Ontogeny of CD4+ T Lymphocytes with Phenotypic Susceptibility to HIV-1 during Exclusive and Non-Exclusive Breastfeeding in HIV-1-exposed Ugandan Infants. J Infect Dis. 2016 Dec 8. pii: jiw553. [Epub ahead of print]. PMID: 27932619.

Keshinro B, Crowell TA, Nowak RG, Adebajo S, Peel S, Gaydos CA, Rodriguez-Hart C, Baral SD, Walsh MJ, Njoku OS, Odeyemi S, Ngo-Ndomb T, Blattner WA, Robb ML, Charurat ME, Ake J; TRUST/RV368 Study Group. 2016. High prevalence of HIV, chlamydia and gonorrhoea among men who have sex with men and transgender women attending trusted community centres in Abuja and Lagos, Nigeria. J Int AIDS Soc. 2016 Dec 7; 19(1):21270. PMID: 27931519. 

Zoubchenok D, Veillette M, Prévost J, Sanders-Buell E, Wagh K, Korber B, Chenine AL, Finzi A. 2016. Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins. J Virol. 2016 Dec 7. pii: JVI.02151-16. [Epub ahead of print]. PMID: 27928014.

Streeck H, Verheyen J, Storim J, Dittmer U, Jochum C, Timm J, Esser S. 2016. Pre-exposure prophylaxis failure with tenofovir disoproxil. AIDS. 2017 Jan 2; 31(1):176-177. PMID: 27898596.

Hannah WN Jr, Hakre S, Dawson P, Wu H, Peel SA, Michael NL, Scott PT, Okulicz JF. 2016. Clinical indicators associated with HIV acquisition in the United States Air Force. AIDS Care. 2016 Nov 28:1-5. [Epub ahead of print]. PMID: 27892711.

Harausz EP, Garcia-Prats AJ, Seddon JA, Schaaf HS, Hesseling AC, Achar J, Bernheimer J, Cruz A, D'Ambrosio L, Detjen A, Graham SM, Hughes J, Jonckheere S, Marais BJ, Battista Migliori G, McKenna L, Skrahina A, Tadolini M, Wilson P, Furin J; Sentinel Project on Pediatric Drug-Resistant Tuberculosis. 2016. New/Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis: Practice-Based Recommendations. Am J Respir Crit Care Med. 2016 Nov 17. [Epub ahead of print]. PMID: 27854508.

Borducchi EN, Cabral C, Stephenson KE, Liu J, Abbink P, Ng'ang'a D, Nkolola JP, Brinkman AL, Peter L, Lee BC, Jimenez J, Jetton D, Mondesir J, Mojta S, Chandrashekar A, Molloy K, Alter G, Gerold JM, Hill AL, Lewis MG, Pau MG, Schuitemaker H, Hesselgesser J, Geleziunas R, Kim JH, Robb ML, Michael NL, Barouch DH. 2016. Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys. Nature. 2016 Dec 8; 540(7632):284-287. PMID: 27841870.

Billings E, Sanders-Buell E, Bose M, Kijak GH, Bradfield A, Crossler J, Arroyo MA, Maboko L, Hoffmann O, Geis S, Birx DL, Kim JH, Michael NL, Robb ML, Hoelscher M, Tovanabutra S. 2016. HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania. AIDS Res Hum Retroviruses. 2016 Dec 19. [Epub ahead of print]. PMID: 27841669.

Mitchell JL, Yankee TM. 2016. Variations in mRNA and protein levels of Ikaros family members in pediatric T cell acute lymphoblastic leukemia. Ann Transl Med. 2016 Oct; 4(19):363. PMID: 27826566.

Peluso MJ, Valcour V, Phanuphak N, Ananworanich J, Fletcher JL, Chalermchai T, Krebs SJ, Robb ML, Hellmuth J, Gisslén M, Zetterberg H, Spudich S; RV254SEARCH 010, RV304SEARCH 013, and SEARCH 011 Study Teams. 2016. Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection. AIDS. 2017 Jan 14; 31(2):247-252. PMID: 27819802.

Blanquart F, Grabowski MK, Herbeck J, Nalugoda F, Serwadda D, Eller MA, Robb ML, Gray R, Kigozi G, Laeyendecker O, Lythgoe KA, Nakigozi G, Quinn TC, Reynolds SJ, Wawer MJ, Fraser C. 2016. A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda. Elife. 2016 Nov 5; 5. pii: e20492. PMID: 27815945.

Colby DJ, Crowell TA, Sirivichayakul S, Pinyakorn S, Kroon E, Benjapornpong K, Intasan J, Trichavaroj R, Tovanabutra S, Robb M, Phanuphak P, Ananworanich J, Phanuphak N; Search 010/RV 254 Study Group. 2016. Declining trend in transmitted drug resistance detected in a prospective cohort study of acute HIV infection in Bangkok, Thailand. J Int AIDS Soc. 2016 Oct 31; 19(1):20966. PMID: 27802846.

Hertz T, Logan MG, Rolland M, Magaret CA, Rademeyer C, Fiore-Gartland A, Edlefsen PT, DeCamp A, Ahmed H, Ngandu N, Larsen BB, Frahm N, Marais J, Thebus R, Geraghty D, Hural J, Corey L, Kublin J, Gray G, McElrath MJ, Mullins JI, Gilbert PB, Williamson C. 2016. A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial. Vaccine. 2016 Nov 11; 34(47):5792-5801. PMID: 27756485.

Ranasinghe S, Lamothe PA, Soghoian DZ, Kazer SW, Cole MB, Shalek AK, Yosef N, Jones RB, Donaghey F, Nwonu C, Jani P, Clayton GM, Crawford F, White J, Montoya A, Power K, Allen TM, Streeck H, Kaufmann DE, Picker LJ, Kappler JW, Walker BD. 2016. Antiviral CD8+ T cells restricted by human leukocyte antigen class II exist during natural HIV infection and exhibit clonal expansion. Immunity. 2016 Oct 18;45(4):917-930. PMID: 27760342.

Rodriguez-Hart C, Liu H, Nowak RG, Orazulike I, Zorowitz S, Crowell TA, Baral SD, Blattner W, Charurat M. 2016. Serosorting and sexual risk for HIV infection at the ego-alter dyadic level: an egocentric sexual network study among MSM in Nigeria. AIDS Behav. 2016 Nov;20(11):2762-2771. PMID: 26910338.

Sereti I, Krebs SJ, Phanuphak N, Fletcher JL, Slike B, Pinyakorn S, O'Connell RJ, Rupert A, Chomont N, Valcour V, Kim JH, Robb ML, Michael NL, Douek DC, Ananworanich J, Utay NS; RV254/SEARCH 010, RV304/SEARCH 013 and SEARCH 011 protocol teams. 2016. Initiation of antiretroviral therapy in early HIV infection reduces but does not abrogate chronic residual inflammation. Clin Infect Dis. 2016 Oct 12. pii: ciw683. [Epub ahead of print]. PMID: 27737952.

Robb ML, Ananworanich J. 2016. Lessons from acute HIV infection. Curr Opin HIV AIDS. 2016 Nov;11(6):555-560. PMID: 27716734.

Harbertson J, Hale BR, Michael NL, Scott PT. 2016. Missed opportunity to screen and diagnose PTSD and depression among deploying shipboard US military personnel. BJPsych Open. 2016 Oct 5;2(5):314-317. PMID: 27713833.

Prasithsirikul W, Chongthawonsatid S, Ohata PJ, Keadpudsa S, Klinbuayaem V, Rerksirikul P, Kerr SJ, Ruxrungtham K, Ananworanich J, Avihingsanon A; PROGRESS study team. 2016. Depression and anxiety were low amongst virally suppressed, long-term treated HIV-infected individuals enrolled in a public sector antiretroviral program in Thailand. AIDS Care. 2016 Aug 10:1-7. [Epub ahead of print]. PMID: 27683949.

Crowell TA, Robb ML. 2016. The doctor's dilemma and vaccine therapy for HIV. Lancet HIV. 2016 Oct;3(10):e450-1. PMID: 27658880.

Crowell TA, Fletcher JL, Sereti I, Pinyakorn S, Dewar R, Krebs SJ, Chomchey N, Rerknimitr R, Schuetz A, Michael NL, Phanuphak N, Chomont N, Ananworanich J; RV254/SEARCH010 Study Group. 2016. Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation. J Int AIDS Soc. 2016 Sep 15;19(1):21163. PMID: 27637172.

Rao M, Alving CR. 2016. Adjuvants for HIV vaccines. Curr Opin HIV AIDS. 2016 Sep 6. [Epub ahead of print]. PMID: 27607594.

Stein J, Storcksdieck Genannt Bonsmann M, Streeck H. 2016. Barriers to HIV Cure. HLA. 2016 Oct; 88(4):155-63. PMID: 27620852.

Ananworanich J, Melvin D, Amador JT, Childs T, Medin G, Boscolo V, Compagnucci A, Kanjanavanit S, Montero S, Gibb DM; PENTA 11 Study Group. 2016. Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption. AIDS 30(7):1075-81. PMID: 26730569.

Jobe O, Trinh HV, Kim J, Alsalmi W, Tovanabutra S, Ehrenberg PK, Peachman KK, Gao G, Thomas R, Kim JH, Michael NL, Alving CR, Rao VB, Rao M. 2016. Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region. J Leukoc Biol 99(6):1089-106. PMID: 26667473. 

Sailasuta N, Ananworanich J, Lerdlum S, Sithinamsuwan P, Fletcher JL, Tipsuk S, Pothisri M, Jadwattanakul T, Jirajariyavej S, Chalermchai T, Catella S, Busovaca E, Desai A, Paul R, Valcour V; SEARCH 011 Study Group. 2016. Neuronal-glia markers by magnetic resonance spectroscopy in HIV before and after combination antiretroviral therapy. J Acquir Immune Defic Syndr 71(1):24-30. PMID: 26258565.

Hu H, Liu F, Kim J, Ratto-Kim S. 2016. HIV susceptibility of human antigen-specific CD4 T cells in AIDS pathogenesis and vaccine response. Expert Rev Vaccines. 15(6):709-17. PMID: 26814372.

Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Ananworanich J, Puthanakit T; Bone-D Study Group. 2016. Hypovitaminosis D and hyperparathyroidism: effects on bone turnover and bone mineral density among perinatally HIV-infected adolescents. AIDS 30(7):1059-67. PMID: 26807972.

Gordon SN, Liyanage NP, Doster MN, Vaccari M, Vargas-Inchaustegui DA, Pegu P, Schifanella L, Shen X, Tomaras GD, Rao M, Billings EA, Schwartz J, Prado I, Bobb K, Zhang W, Montefiori DC, Foulds KE, Ferrari G, Robert-Guroff M, Roederer M, Phan TB, Forthal DN, Stablein DM, Phogat S, Venzon DJ, Fouts T, Franchini G. 2016. Boosting of ALVAC-SIV vaccine-primed Macaques with the CD4-SIVgp120 fusion protein elicits antibodies to V2 associated with a decreased risk of SIVmac251 acquisition. J Immunol. 2016 Sep 2. pii: 1600674. [Epub ahead of print]. PMID: 27591322.

Streeck H. 2016. Designing optimal HIV-vaccine T-cell responses. Curr Opin HIV AIDS. 2016 Aug 24. [Epub ahead of print]. PMID: 27559707.

Abbink P, Larocca RA, De La Barrera RA, Bricault CA, Moseley ET, Boyd M, Kirilova M, Li Z, Ng’ang’a D, Nanayakkara O, Nityanandam R, Mercado NB, Borducchi EN, Agarwal1 A, Brinkman AL, Cabral C, Chandrashekar A, Giglio PB, Jetton D, Jimenez J, Lee BC, Mojta S, Molloy K, Shetty M, Neubauer GH, Stephenson KE, Peron JPS, de A. Zanotto PM, Misamore J, Finneyfrock B, Lewis MG, Alter G, Modjarrad K, Jarman RG, Eckels KH, Michael NL, Thomas SJ, Barouch DH. 2016. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science. 04 Aug 2016. doi: 10.1126/science.aah6157. PMID: 27492477.

Manak MM, Hack HR, Nair SV, Worlock A, Malia JA, Peel SA, Jagodzinski LL. 2016. Evaluation of Hologic Aptima HIV-1 Quant Dx Assay on the Panther System on HIV Subtypes. J Clin Microbiol. 2016 Aug 10. pii: JCM.01350-16. [Epub ahead of print]. PMID: 27510829.

Heipertz RA Jr, Ayemoba O, Sanders-Buell E, Poltavee K, Pham P, Kijak GH, Lei E, Bose M, Howell S, OʼSullivan AM, Bates A, Cervenka T, Kuroiwa J, Akintunde A, Ibezim O, Alabi A, Okoye O, Manak M, Malia J, Peel S, Maisaka M, Singer D, O'Connell RJ, Robb ML, Kim JH, Michael NL, Njoku O, Tovanabutra S. 2016. Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG. Medicine (Baltimore) 95(32):e4346. PMID: 27512845.

Hakre S, Blaylock JM, Dawson P, Beckett C, Garges EC, Michael NL, Danaher PJ, Scott PT, Okulicz JF. 2016. Knowledge, attitudes, and beliefs about HIV pre-exposure prophylaxis among US Air Force Health Care Providers. Medicine (Baltimore) 95(32):e4511. PMID: 27512869.

Excler JL, Michael NL. 2016. Lessons from HIV-1 vaccine efficacy trials. Curr Opin HIV AIDS. 2016 Aug 16. [Epub ahead of print]. PMID: 27537673.

Demers KR, Makedonas G, Buggert M, Eller MA, Ratcliffe SJ, Goonetilleke N, Li CK, Eller LA, Rono K, Maganga L, Nitayaphan S, Kibuuka H, Routy JP, Slifka MK, Haynes BF, McMichael AJ, Bernard NF, Robb ML, Betts MR. 2016. Temporal dynamics of CD8+ T cell effector responses during primary HIV infection. PLoS Pathog 12(8):e1005805. PMID: 27486665.

Fidler S, Ananworanich J, Vandekerckhove L, Kiselinova M, Schuetz A, Vera JH, Dwyer E, Alagaratnam J. 2016. Highlights from the Conference on Retroviruses and Opportunistic Infections 2016: 22-25 February 2016, Boston, Massachusetts, USA. J Virus Erad 2(2):124-30. PMID: 27482450.

Johnston R, Pinyakorn S, Ananworanich J. 2016. Is there gender bias in HIV cure research? A case study of female representation at the 2015 HIV Persistence Workshop. J Virus Erad 2(2):117-20. PMID: 27482448.

Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Sohn AH, Ananworanich J, Puthanakit T; Bone-D Study Group. 2016. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression. HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12418. [Epub ahead of print]. PMID: 27477214.

Muir R, Metcalf T, Tardif V, Takata H, Phanuphak N, Kroon E, Colby DJ, Trichavaroj R, Valcour V, Robb ML, Michael NL, Ananworanich J, Trautmann L, Haddad EK; RV254/SEARCH010 RV304/SEARCH 013 Study Groups. 2016. Altered memory circulating T follicular helper-B cell interaction in early acute HIV infection. PLoS Pathog 12(7):e1005777. PMID: 27463374.

Ananworanich J, Chomont N, Eller LA, Kroon E, Tovanabutra S, Bose M, Nau M, Fletcher JL, Tipsuk S, Vandergeeten C, O'Connell RJ, Pinyakorn S, Michael N, Phanuphak N, Robb ML; RV217 and RV254/SEARCH010 study groups. 2016. HIV DNA set point is rapidly established in acute HIV infection and dramatically reduced by early ART. EBioMedicine. 2016 Jul 20. doi: 10.1016/j.ebiom.2016.07.024. [Epub ahead of print]. PMID: 27460436.

Deleage C, Schuetz A, Alvord WG, Johnston L, Hao XP, Morcock DR, Rerknimitr R, Fletcher JL, Puttamaswin S, Phanuphak N, Dewar R, McCune JM, Sereti I, Robb M, Kim JH, Schacker TW, Hunt P, Lifson JD, Ananworanich J, Estes JD. 2016. Impact of early cART in the gut during acute HIV infection. JCI Insight 1(10). PMID: 27446990.

Rademeyer C, Korber B, Seaman MS, Giorgi EE, Thebus R, Robles A, Sheward DJ, Wagh K, Garrity J, Carey BR, Gao H, Greene KM, Tang H, Bandawe GP, Marais JC, Diphoko TE, Hraber P, Tumba N, Moore PL, Gray GE, Kublin J, McElrath MJ, Vermeulen M, Middelkoop K, Bekker LG, Hoelscher M, Maboko L, Makhema J, Robb ML, Abdool Karim S, Abdool Karim Q, Kim JH, Hahn BH, Gao F, Swanstrom R, Morris L, Montefiori DC, Williamson C. 2016. Features of recently transmitted HIV-1 clade C viruses that impact antibody recognition: Implications for active and passive immunization. PLoS Pathog. 12(7):e1005742. PMID: 27434311.

Deeks SG, Lewin SR, Ross AL, Ananworanich J, Benkirane M, Cannon P, Chomont N, Douek D, Lifson JD, Lo YR, Kuritzkes D, Margolis D, Mellors J, Persaud D, Tucker JD, Barre-Sinoussi F; International AIDS Society Towards a Cure Working Group, Alter G, Auerbach J, Autran B, Barouch DH, Behrens G, Cavazzana M, Chen Z, Cohen ÉA, Corbelli GM, Eholié S, Eyal N, Fidler S, Garcia L, Grossman C, Henderson G, Henrich TJ, Jefferys R, Kiem HP, McCune J, Moodley K, Newman PA, Nijhuis M, Nsubuga MS, Ott M, Palmer S, Richman D, Saez-Cirion A, Sharp M, Siliciano J, Silvestri G, Singh J, Spire B, Taylor J, Tolstrup M, Valente S, van Lunzen J, Walensky R, Wilson I, Zack J. 2016. International AIDS Society global scientific strategy: towards an HIV cure 2016. Nat Med. 2016 Jul 11. doi: 10.1038/nm.4108. [Epub ahead of print]. PMID: 27400264.

Modjarrad K, Moorthy VS, Ben Embarek P, Van Kerkhove M, Kim J, Kieny MP. 2016. A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation. Nat Med 22(7):701-705. doi: 10.1038/nm.4131. PMID: 27387881.

Mafukidze A, Harausz E, Furin J. 2016. An update on repurposed medications for the treatment of drug-resistant tuberculosis. Expert Rev Clin Pharmacol. 2016 Jul 4. [Epub ahead of print]. PMID: 27376490.

Prasitsuebsai W, Teeraananchai S, Singtoroj T, Truong KH, Ananworanich J, Do VC, Nguyen LV, Kosalaraksa P, Kurniati N, Sudjaritruk T, Chokephaibulkit K, Kerr SJ, Sohn AH. 2016. Treatment outcomes and resistance patterns of children and adolescents on second-line antiretroviral therapy in Asia. J Acquir Immune Defic Syndr. 2016 Aug 1;72(4):380-6. doi: 10.1097/QAI.0000000000000971.PMID: 27355415.

Condit RC, Williamson AL, Sheets R, Seligman SJ, Monath TP, Excler JL, Gurwith M, Bok K, Robertson JS, Kim D, Michael Hendry R, Singh V, Mac LM, Chen RT; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). 2016. Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains. Vaccine. 2016 Jun 23. pii: S0264-410X(16)30225-0. doi: 10.1016/j.vaccine.2016.04.060. [Epub ahead of print]. PMID: 27346303.

de Souza MS, Pinyakorn S, Akapirat S, Pattanachaiwit S, Fletcher JL, Chomchey N, Kroon ED, Ubolyam S, Michael NL, Robb ML, Phanuphak P, Kim JH, Phanuphak N, Ananworanich J; RV254/SEARCH010 Study Group. 2016. Initiation of antiretroviral therapy during acute HIV-1 lnfection leads to a high rate of non-reactive HIV serology. Clin Infect Dis. 2016 Jun 17 pii:ciw365. [Epub ahead of print]. PMID: 27317797.

Larocca RA, Abbink P, Peron JP, Zanotto PM, Iampietro MJ, Badamchi-Zadeh A, Boyd M, Ng'ang'a D, Kirilova M, Nityanandam R, Mercado NB, Li Z, Moseley ET, Bricault CA, Borducchi EN, Giglio PB, Jetton D, Neubauer G, Nkolola JP, Maxfield LF, Barrera RA, Jarman RG, Eckels KH, Michael NL, Thomas SJ, Barouch DH. 2016. Vaccine protection against Zika virus from Brazil. Nature. 2016 Jun 28. doi: 10.1038/nature18952. [Epub ahead of print]. PMID: 27355570.

Giersing BK, Modjarrad K, Kaslow DC, Okwo-Bele JM, Moorthy VS. 2016. The 2016 Vaccine Development Pipeline: A special issue from the World Health Organization Product Development for Vaccine Advisory Committee (PDVAC). Vaccine 34(26):2863-2864. PMID: 27108194.

Giersing BK, Dastgheyb SS, Modjarrad K, Moorthy V. 2016. Status of vaccine research and development of vaccines for Staphylococcus aureus. Vaccine 34(26):2962-2966. PMID: 27105559.

Modjarrad K. 2016. MERS-CoV vaccine candidates in development: The current landscape. Vaccine 34(26):2982-2987. PMID: 27083424.

Todd CS, Mansoor GF, Buhler C, Rahimi H, Zekria R, Fernandez S, Mikhail AF, Scott PT, Yingst SL. 2016. Prevalence of zoonotic and vector-borne infections among Afghan National Army recruits in Afghanistan. Vector Borne Zoonotic Dis. 2016 Jun 15. [Epub ahead of print]. PMID: 27304051.

Hellmuth J, Fletcher JL, Valcour V, Kroon E, Ananworanich J, Intasan J, Lerdlum S, Narvid J, Pothisri M, Allen I, Krebs SJ, Slike B, Prueksakaew P, Jagodzinski LL, Puttamaswin S, Phanuphak N, Spudich S; SEARCH 010/RV254 Study Group. 2016. Neurologic signs and symptoms frequently manifest in acute HIV infection. Neurology. 2016 Jun 10. pii: 10.1212/WNL.0000000000002837. [Epub ahead of print]. PMID: 27287217.

Liu F, Fan X, Auclair S, Ferguson M, Sun J, Soong L, Hou W, Redfield RR, Birx DL, Ratto-Kim S, Robb ML, Kim JH, Michael NL, Hu H. 2016. Sequential dysfunction and progressive depletion of candida albicans-specific CD4 T Cell response in HIV-1 infection. PLoS Pathog 12(6):e1005663. PMID: 27280548.

Rolland M. 2016. HIV-1 immune evasion-a threat to effective vaccines? Nat Med 22(6):580-581. PMID: 27270774.

Ananworanich J, Abrams EJ. 2016. Time to prioritise the UNAIDS 90-90-90 targets for infants. Lancet HIV 3(6):e241-3. doi: 10.1016/S2352-3018(16)30013-3. PMID: 27240784.

Vaccari M, Gordon SN, Fourati S, Schifanella L, Liyanage NP, Cameron M, Keele BF, Shen X, Tomaras GD, Billings E, Rao M, Chung AW, Dowell KG, Bailey-Kellogg C, Brown EP, Ackerman ME, Vargas-Inchaustegui DA, Whitney S, Doster MN, Binello N, Pegu P, Montefiori DC, Foulds K, Quinn DS, Donaldson M, Liang F, Loré K, Roederer M, Koup RA, McDermott A, Ma ZM, Miller CJ, Phan TB, Forthal DN, Blackburn M, Caccuri F, Bissa M, Ferrari G, Kalyanaraman V, Ferrari MG, Thompson D, Robert-Guroff M, Ratto-Kim S, Kim JH, Michael NL, Phogat S, Barnett SW, Tartaglia J, Venzon D, Stablein DM, Alter G, Sekaly RP, Franchini G. 2016. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016 May 30:doi: 10.1038/nm.4105. [Epub ahead of print]. PMID: 27239761.

Stahlman S, Nowak RG, Liu H, Crowell TA, Ketende S, Blattner WA, Charurat ME, Baral SD; TRUST/RV368 Study Group. 2016. Online sex-seeking among men who have sex with men in Nigeria: implications for online intervention. AIDS Behav. 2016 May 27. [Epub ahead of print]. PMID: 27233248.

Robb ML, Eller LA, Kibuuka H, Rono K, Maganga L, Nitayaphan S, Kroon E, Sawe FK, Sinei S, Sriplienchan S, Jagodzinski LL, Malia J, Manak M, de Souza MS, Tovanabutra S, Sanders-Buell E, Rolland M, Dorsey-Spitz J, Eller MA, Milazzo M, Li Q, Lewandowski A, Wu H, Swann E, O'Connell RJ, Peel S, Dawson P, Kim JH, Michael NL; RV 217 Study Team. 2016. Prospective study of acute HIV-1 infection in adults in East Africa and Thailand. N Engl J Med 2016 May 18. [Epub ahead of print]. PMID: 27192360.

Joachim A, Bauer A, Joseph S, Geldmacher C, Munseri PJ, Aboud S, Missanga M, Mann P, Wahren B, Ferrari G, Polonis VR, Robb ML, Weber J, Tatoud R, Maboko L, Hoelscher M, Lyamuya EF, Biberfeld G, Sandström E, Kroidl A, Bakari M, Nilsson C, McCormack S. 2016. Boosting with subtype C CN54rgp140 protein adjuvanted with glucopyranosyl lipid adjuvant after priming with HIV-DNA and HIV-MVA is safe and enhances immune responses: a phase I trial. PLoS One 11(5):e0155702. PMID: 27192151.

Apps R, Del Prete GQ, Chatterjee P, Lara A, Brumme ZL, Brockman MA, Neil S, Pickering S, Schneider DK, Piechocka-Trocha A, Walker BD, Thomas R, Shaw GM, Hahn BH, Keele BF, Lifson JD, Carrington M. 2016. HIV-1 Vpu mediates HLA-C downregulation. Cell Host Microbe 19(5):686-95. PMID: 27173934.

Scherpbier HJ, Terpstra V, Pajkrt D, Puthakanit T, Ananworanich J, Foster C, van den Bergh Weerman M, Deurloo EE, van der Valk M, Kuijpers TW, Koot BG. 2016. Noncirrhotic portal hypertension in perinatally HIV-infected adolescents treated with didanosine-containing antiretroviral regimens in childhood. Pediatr Infect Dis J. 2016 May 10. [Epub ahead of print]. PMID: 27167116.​

Crowell TA, Phanuphak N, Pinyakorn S, Kroon E, Fletcher JL, Colby D, Tipsuk S, Karnsomlap P, Laopraynak N, O'Connell RJ, Robb ML, Ananworanich J; RV254SEARCH010 Study Group. 2016. Virologic failure is uncommon after treatment initiation during acute HIV infection. AIDS. 2016 May 9. [Epub ahead of print]. PMID: 27163706.

Torres OB, Alving CR, Matyas GR. 2016. Synthesis of hapten-protein conjugate vaccines with reproducible hapten densities. Methods Mol Biol 1403:695-710. PMID: 27076161.

Harbertson J, Hale BR, Watkins EY, Michael NL, Scott PT. 2016. Pre-deployment alcohol misuse among shipboard active-duty U.S. military personnel. Am J Prev Med doi: 10.1016/j.amepre.2016.02.029. [Epub ahead of print]. PMID: 27067304.

Trautmann L. 2016. Kill: Boosting HIV specific immune response. Curr Opin HIV AIDS 2016 Apr 6. [Epub ahead of print]. PMID: 27054280.

Mahan AE, Jennewein MF, Suscovich T, Dionne K, Tedesco J, Chung AW, Streeck H, Pau M, Schuitemaker H, Francis D, Fast P, Laufer D, Walker BD, Baden L, Barouch DH, Alter G. 2016. Antigen-specific antibody glycosylation is regulated via vaccination. PLoS Pathog 12(3):e1005456. PMID: 26982805.

Gunn BM, Schneider JR, Shansab M, Bastian AR, Fahrbach KM, Smith AD 4th, Mahan AE, Karim MM, Licht AF, Zvonar I, Tedesco J, Anderson MR, Chapel A, Suscovich TJ, Malaspina DC, Streeck H, Walker BD, Kim A, Lauer G, Altfeld M, Pillai S, Szleifer I, Kelleher NL, Kiser PF, Hope TJ, Alter G. 2016. Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16. Mucosal Immunol 2016 Mar 9. doi: 10.1038/mi.2016.8. [Epub ahead of print]. PMID: 26960182.

​Wansom T, Guadamuz TE, Vasan S. 2016. Transgender populations and HIV: Unique risks, challenges and opportunities.  J Virus Erad 2: 87-93.

Polyak CS, Yuhas K, Singa B, Khaemba M, Walson J, Richardson BA, John-Stewart G. 2016. Cotrimoxazole prophylaxis discontinuation among antiretroviral-treated HIV-1 infected adults in Kenya: a randomized non-inferiority trial. PLoS Med 13(1): e1001934. PMID: 26731191.

Rodriguez-Hart C, Liu H, Nowak RG, Orazulike I, Zorowitz S, Crowell TA, Baral SD, Blattner W, Charurat M. 2016. Serosorting and sexual risk for HIV infection at the ego-alter dyadic level: an egocentric sexual network study among MSM in Nigeria. AIDS Behav 2016 Feb 24 [Epub ahead of print]. PMID: 26910338.

Akkina R, Allam A, Balazs AB, Blankson JN, Burnett JC, Casares S, Garcia JV, Hasenkrug KJ, Kashanchi F, Kitchen SG, Klein F, Kumar P, Luster AD, Poluektova LY, Rao M, Sanders-Beer BE, Shultz LD, Zack JA. 2016. Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary. AIDS Res Hum Retroviruses 32(2):109-119. PMID: 26670361.

Giersing BK, Modjarrad K, Kaslow DC, Moorthy VS; WHO Product Development for Vaccines Product Development Advisory Committee. 2016. Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7-9th Sep 2015. Vaccine pii: S0264-410X(16)00291-7. PMID: 26993336.

Alving CR, Beck Z, Matyas GR, Rao M. 2016. Liposomal adjuvants for human vaccines. Expert Opin Drug Deliv 2016 Feb 25: 1-10 [Epub ahead of print]. PMID: 26866300.

Hessell AJ, Malherbe DC, Pissani F, McBurney S, Krebs SJ, Gomes M, Pandey S, Sutton WF, Burwitz BJ, Gray M, Robins H, Park BS, Sacha JB, LaBranche CC, Fuller DH, Montefiori DC, Stamatatos L, Sather DN, Haigwood NL. 2016. Achieving potent autologous neutralizing antibody responses against Tier 2 HIV-1 viruses by strategic selection of envelope immunogens. J Immunol 196(7): 3064-3078. PMID: 26944928.

Kancheva Landolt N, Bunupuradah T, Kosalaraksa P, Ubolyam S, Thammajaruk N, Cremers S, Zott R, Kerr S, Ananworanich J; HIV-NAT 176 study. 2016. High variability of hormonal levels and no clinically relevant interaction between ethinyl estradiol, desogestrel and lopinavir/ritonavir in a small sample of HIV-positive adolescents. J Acquir Immune Defic Syndr 2016 Mar 16 [Epub ahead of print]. PMID: 26990825.

Krebs SJ, Slike BM, Sithinamsuwan P, Allen IE, Chalermchai T, Tipsuk S, Phanuphak N, Jagodzinski L, Kim JH, Ananworanich J, Marovich MA, Valcour VG; SEARCH 011 study team. 2016. Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV infected individuals. AIDS. 2016 Mar 16 [Epub ahead of print]. PMID: 26990631.

Palma P, Foster C, Rojo P, Zangari P, Yates A, Cotugno N, Klein N, Luzuriaga K, Pahwa S, Nastouli E, Gibb DM, Borkowsky W, Bernardi S, Calvez V, Manno E, Mora N, Compagnucci A, Wahren B, Muñoz-Fernández M, De Rossi A, Ananworanich J, Pillay D, Giaquinto C, Rossi P. 2016. The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children. J Virus Erad 1(3): 134-139. PMID: 26893908.

O'Connell RJ, Excler JL, Polonis VR, Ratto-Kim S, Cox J, Jagodzinski LL, Liu M, Wieczorek L, McNeil JG, El-Habib R, Michael NL, Gilliam BL, Paris R, VanCott TC, Tomaras GD, Birx DL, Robb ML, Kim JH. 2016. Safety and immunogenicity of a randomized phase 1 prime-boost trial with ALVAC-HIV (vCP205) and oligomeric glycoprotein 160 from HIV-1 strains MN and LAI-2 adjuvanted in alum or polyphosphazene. J Infect Dis 2016 Feb 11: pii: jiw059 [Epub ahead of print]. PMID: 26908741.

Ananworanich J, Sacdalan CP, Pinyakorn S, Chomont N, de Souza M, Luekasemsuk T, Schuetz A, Krebs SJ, Dewar R, Jagodzinski L, Ubolyam S, Trichavaroj R, Tovanabutra S, Spudich S, Valcour V, Sereti I, Michael N, Robb M, Phanuphak P, Kim JH, Phanuphak N. 2016. Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection. J Virus Erad 2: 43-48. PMID: 26889497.

Crowell TA, Ganesan A, Berry SA, Deiss RG, Agan BK, Okulicz JF; Infectious Disease Clinical Research Program (IDCRP) HIV Working Group. 2016. Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. Military HIV Natural History Study. J Int AIDS Soc 19(1):20524. PMID: 26955965.

Olwenyi OA, Naluyima P, Cham F, Quinn TC, Serwadda D, Sewankambo NK, Gray RH, Sandberg JK, Michael NL, Wabwire-Mangen F, Robb ML, Eller MA. 2015. Differential associations of IL-6 and intestinal fatty acid-binding protein with progressive untreated HIV-1 infection in Rakai, Uganda. J Acquir Immune Defic Syndr 2015 Dec 1. [Epub ahead of print]. PMID: 26630672.

Grossman CI, Ross AL, Auerbach JD, Ananworanich J, Dubé K, Tucker JD, Noseda V, Possas C, Rausch DM; International AIDS Society (IAS) ‘Towards an HIV Cure’ initiative. 2016. Towards Multidisciplinary HIV-Cure Research: Integrating Social Science with Biomedical Research. Trends Microbiol 24(1): 5-11. PMID: 26642901.

Eller MA, Goonetilleke N, Tassaneetrithep B, Eller LA, Costanzo MC, Johnson S, Betts MR, Krebs SJ, Slike BM, Nitayaphan S, Rono K, Tovanabutra S, Maganga L, Kibuuka H, Jagodzinski L, Peel S, Rolland M, Marovich MA, Kim JH, Michael NL, Robb ML, Streeck H. 2016. Expansion of inefficient HIV-specific CD8+ T cells during acute infection. J Virol JVI.02785-15. [Epub ahead of print]. PMID: 26842474.

Tartaglia LJ, Chang HW, Lee BC, Abbink P, Ng'ang'a D, Boyd M, Lavine CL, Lim SY, Sanisetty S, Whitney JB, Seaman MS, Rolland M, Tovanabutra S, Ananworanich J, Robb ML, Kim JH, Michael NL, Barouch DH. Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences. PLoS Pathog 12(2):e1005431. PMID: 26849216.

Modjarrad, K. 2016. Treatment strategies for Middle East respiratory syndrome coronavirus.​ J Virus Erad 1(2)​:1-4. PMID: 26866060.

Ananworanich J, Chomont N, Fletcher JL, Pinyakorn S, Schuetz A, Sereti I, Rerknimitr R, Dewar R, Kroon E, Vandergeeten C, Trichavaroj R, Chomchey N, Chalermchai T, Michael NL, Kim JH, Phanuphak P, Phanuphak N. 2016. Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification. J Virus Erad 1(2): 116-122. PMID: 26835516.

Naluyima P, Eller LA, Ouma BJ, Kyabaggu D, Kataaha P, Guwatudde D, Kibuuka H. Wabwire-Mangen F, Robb ML, Michael NL, de Souza MS, Sandberg JK, Eller MA.  2016. Sex and urbanicity contribute to variation in lymphocyte distribution across Ugandan populations. PLoS One 11(1): e0146196. PMID: 26730706.

Merbah M, Onkar S, Grivel JC, Vanpouille C, Biancotto A, Bonar L, Sanders-Buell E, Kijak G, Michael N, Robb M, Kim JH, Tovanabutra S, Chenine AL. 2016. Standardization of a cytometric p24-capture bead-assay for the detection of main HIV-1 subtypes. J Virol Methods 2016 Jan 22: doi: 10.1016/j.jviromet.2016.01.009. [Epub ahead of print]. PMID: 26808359.

Schultz BT, Teigler JE, Pissani F, Oster AF, Kranias G, Alter G, Marovich M, Eller MA, Dittmer U, Robb ML, Kim JH, Michael NL, Bolton D, Streeck H. 2016. Circulating HIV-specific interleukin-21(+)CD4(+) T cells represent peripheral Tfh cells with antigen-dependent helper functions. Immunity 44(1): 167-178. PMID: 26795249.

Torres OB, Antoline JF, Li F, Jalah R, Jacobson AE, Rice KC, Alving CR, Matyas GR. 2016. A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuse. Anal Bioanal Chem 408(4): 1191-1204. PMID: 26677020.